Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Lenexa, Kansas 66219


Purpose:

The purpose of this study is to compare the sweetness of 2 new Atazanavir (ATV) powder for oral use (POU) formulations to the current ATV POU in healthy subjects and to select one ATV POU that has the sweetness most similar to the current ATV POU.


Study summary:

Primary Purpose: This study is a taste assessment study to select a new Atazanavir powder for oral use (POU) formulation that is similar sweetness to the current POU formulation. Subjects will be tasting and then spitting the POU formulations and will not be swallowing the POU formulations that will be tested. Study Classification: Other. This is a taste study


Criteria:

Inclusion Criteria: - Healthy men and women, ages 18 to 49, inclusive - Nonsmokers - Women not pregnant or breastfeeding - Subjects who can match solutions that are the same in sweetness and provide consistent sweetness scores during the taste screening Exclusion Criteria: - Positive urine drug screen (UDS) - Positive urine screen for cotinine - Positive Hepatitis C antibody, Hepatitis B surface antigen, or Human Immunodeficiency Virus antibodies - Clinically significant elevations of liver function tests above normal range


NCT ID:

NCT01404572


Primary Contact:

Study Director
Bristol-Myers Squibb
Bristol-Myers Squibb


Backup Contact:

N/A


Location Contact:

Lenexa, Kansas 66219
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.